CINDY BALDONADO: Open Payments
NPI 1851425417 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 20 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $474 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Novo Nordisk Inc | 6 | $107 |
| Lilly USA, LLC | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, MOUNJARO, REXULTI, PREVNAR 20, BREZTRI, ULTOMIRIS.
Industry payments across CA — which companies pay providers there.
